• S2 Episode 2: Can Psoriasis Care Limit CVD, PsA, and Depression?

  • Apr 25 2023
  • Duración: 26 m
  • Podcast

S2 Episode 2: Can Psoriasis Care Limit CVD, PsA, and Depression?  Por  arte de portada

S2 Episode 2: Can Psoriasis Care Limit CVD, PsA, and Depression?

  • Resumen

  • Dr Steve Feldman speaks with Drs Mehta, Ritchlin, and Fried who share an exciting new roadmap for calming key psoriasis comorbidities.

    Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/986151). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

    Resources

    Treatment of Psoriasis With Biologic Therapy Is Associated With Improvement of Coronary Artery Plaque Lipid-rich Necrotic Core: Results From a Prospective, Observational Study https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.120.011199

    Treating the Skin With Biologics in Patients With Psoriasis Decreases the Incidence of Psoriatic Arthritis https://pubmed.ncbi.nlm.nih.gov/34281904/

    The Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener https://pubmed.ncbi.nlm.nih.gov/14583691/

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre S2 Episode 2: Can Psoriasis Care Limit CVD, PsA, and Depression?

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.